Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design | Trials | Full Text

Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design | Trials | Full Text

Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design

The symptom severity of a substantial group of schizophrenia patients (30–40%) does not improve through pharmacotherapy with antipsychotic medication, indicating a clear need for new treatment options to impro...

Authors:Lyliana G. Nasib, Iris E. Sommer, Inge Winter - van Rossum, Jacqueline de Vries, Shiral S. Gangadin, Priscilla P. Oomen, Gurmeet Judge, Renske E. Blom, Jurjen J. Luykx, Nico J. M. van Beveren, Natalie D. Veen, Rune A. Kroken and Erik L. Johnsen

Citation:Trials 2020 21:492

Content type:Study protocol

 

Published on: 8 June 2020

• ViewFull Text
 
• ViewPDF